Applied Air Lawyers February 18, 2025 February 18, 2025 Hungry Dress Hungry-Point Dress Wespedings.

New York – January 25, 2025 (NEW YORK) — CAPLAN FARX & Killimer LLP (Applied Therapeutics or Company) (NASDAQ: APTT ) Investors who have applied for Trafficix security on January 3, 2024 or purchased on December 2, 2024 (class period).

Click here to join the issue

If you are an investor in applied therapeutics and have experience, you can click here to contact us. You can also contact Kaplan Fox by emailing jcmpisi@kplanofx.com or calling 212-8571.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than February 18, 2025 to serve as a lead plaintiff for the purported class. It encourages you to learn more about the lead plaintiff process if you have a loss. You don’t have to be the lead defendant to share in any recovery.

On November 27, 2024, according to the petition, the US Food and Drug Administration (FDA) stated that it is a complete responder to the new drug application. Galactose (NDA). Associated press freedoms (d) F.D.

Following this news On November 29, 2024, the stock fell more than 76% to close at $2.03 on heavy trading volume at $6.54.

Then after the markets closed on December 2, 2020 8 kg following the reception of the cream. The company is 8 km. Issues that relate to the level of electronic information delivery before patients before the success of the maintenance recovery and transfer the levels of attack with the number of protection. According to the petition, the share price of applied provinces will be divided from the closing market price of $1.75 on December 5, 2024 to close at $1.29 per share.

Why contact KAPLAN FAX – Kaplan FAX is the leading law firm focused on the complex territories of New York, Los Angeles, Chicago and New Jersey. Kapila offers professional experience with more than 50 years of experience in the field and keeps a record of customer inquiries. At the federal and state level, he has successfully reflected on the law by winning many important decisions on behalf of our clients. For more information about KAPLAN Fox & Kilmer LLP, you can visit our website at www.kaplanfox.com.

This press release may be considered an announcement by a lawyer in certain cases in accordance with applicable law and ethical rules.

If you have any questions about this notice, your rights or interests, please contact:

Address

Jeffrey P. Camcc

KAPLAN FAX & KILLIME LLP

800 Third Street, 38th Floor

New York, New York 10022

(212) 329-8571

jscpicisi@kaplanfofofox.com

Laurence D. King

KAPLAN FAX & KILLIME LLP

In the year 1999 Harrison Ave., Suite 1560

Oakland, California 94612

(415) 772-4704

heouk@kplafofx.com

Check out the first release at www.newemedirewire.com

Copyright 2025 JCN LESTWire. All rights reserved.